The imminent threat of a terrorist attack in the United States involving chemical agents has created new challenges for homeland security (https://www.ninds.nih.gov/current-research/trans-agency-activities/counteract-program). In research aimed to counteract the ocular damage caused by chemical injury, the principal investigator Royce Mohan and co-investigator Paola Bargagna-Mohan have developed innovative insights into how corneal Schwann cells help to restore sensory function. This new grant from the NIH CounterACT program will support innovative research to develop drug therapies for improving axonal regeneration in chemical injury and pave the way for effective treatments for other unmet clinical conditions.